Anti Suicide Drugs Market Size, Share and Growth Analysis to 2025

Anti-Suicide Drugs Market Size and Growth Rate:

 

The ****** Anti-Suicide Drugs Market was valued at US$ 3,514.3 Mn in 2018 and is expected to grow at a significant CAGR over six years forecast period 2019-2025 owing to growing number of suicide rates across the world”

 

Anti-Suicide Drugs Market Growth Drivers and Restraints:

 

The ****** Anti-Suicide drugs market was valued at US$ 3,514.3 Mn in 2018 and growing at a CAGR of 4.2% over the forecast period owing to growing population with psychotic disorders, clinical depressive syndrome, and depression are the major driving factors for the growth of the market over the forecast years. Increasing suicidal rates across the globe, for instance, according to the WHO, more than 800K deaths are happening every year are suicide cases. The number of suicide cases are increasing owing to economic crisis with in the family and social negligence coupled with rapid adoption of new therapies for anti-suicides fuels the growth of the market. However, rising abuse of drugs, lack of effective therapies available for suicide cases are anticipated to restrain the growth of the market.

 

Browse More Insights of the report @ https://www.precisionbusinessinsights.com/market-reports/******-anti-suicide-drugs-market/

 

NMDA antagonists segment accounted for higher revenue share

 

Based on drug class, ****** Anti-Suicide drugs market is segmented into Anti-depressants, Anti-anxiety drugs, Anti-psychotic drugs, NMDA Antagonists, and Antibiotic analogues. NMDA antagonists segment accounted for the largest market share in 2018 and is expected to grow with highest CAGR over the forecast period owing to launch of new products in the market and increasing number of studies for the approval of new drugs are expected to boost the growth of the market. Anti-psychotic drugs, anti-depressants are also expected to fuel in the future years with significant growth rate.

North America holds leading position in ****** Anti-Suicide Drugs Market

 

PBI’s ****** Anti-Suicide drugs market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to regional analysis, North America is expected to account for larger revenue share in 2018 and the same trend is projected to follow over 2019-2025 owing to rising occurrence of suicidal cases, increase in healthcare spending and launch of various anti-suicidal drugs. As per, 2014 estimations of American Foundation for Suicide Prevention, the suicide rate in U.S was around 12.93 /1,000 people. Developing countries in APAC region are anticipated to show the significant growth throughout the forecast period owing to increasing awareness about the mental health, increasing visits of people to psychiatrists and psychologists, upsurge in the number of associations which are working on spreading the awareness, and increasing suicide incidences. According to the data estimation of WHO in 2012, India, Russia, Guyana, Republic of Korea, Sri Lanka, Japan, and Kazakhstan are the nations with high suicidal rates.

Recent Developments in the ****** Anti-Suicide Drugs Market

 

  • In 2015 August, acquired Naurex Inc., a clinical-stage biopharmaceutical company of developing transformative therapies for CNS disorders.
  • In October 2013, H. Lundbeck A/S and Takeda pharmaceutical company jointly received U.S FDA approval for Brintellix (vortioxetine) to treat a Major depressive disorder in adults.

 

Key player’s profiles in the report are AstraZeneca plc (UK), Allergan plc, Eli Lilly and Company (UK), H. Lundbeck A/S (Denmark), GlaxoSmithKline plc (UK), Johnson & Johnson (U.S), Merck & Co., Inc. (U.S), Pfizer, Inc. (U.S) to name some few.

 

Avail Sample of the report @ https://www.precisionbusinessinsights.com/request-sample?product_id=17036

 

Detailed Segmentation of Anti-Suicide Drugs Market:

 

By Drug Class

  • Anti-depressants
  • Anti-anxiety drugs
  • Anti-psychotic drugs
  • NMDA Antagonists
  • Antibiotic analogues

 

By Route of Administration

  • Oral
  • Parenteral

 

 By Distribution Channel  

  • Hospitals
  • Clinics
  • Online pharmacies
  • Retail pharmacies

 

Geography

 

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

About Us:

 

Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights.

 

Contact Us:

 

Shreya Paul

Senior Business Development Executive

Email @ shreya@precisionbusinessinsights.com

Call @ +1-866-598-1553

Precision Business Insights

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.